Live Breaking News & Updates on Biovaxys or company

Stay informed with the latest breaking news from Biovaxys or company on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biovaxys or company and stay connected to the pulse of your community

BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE

/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has received a Notice of Allowance...

United-kingdom , Vancouver , British-columbia , Canada , Australia , United-states , Japan , Spain , Frankfurt , Brandenburg , Germany , British

BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.

VANCOUVER, BC, Feb. 21, 2024 /PRNewswire/ -- BioVaxys Technology Corp. is pleased to announce has completed the acquisition of the entire portfolio of discovery, preclinical and clinical...

United-kingdom , Spain , Vancouver , British-columbia , Canada , United-states , Frankfurt , Brandenburg , Germany , Canadian , British , Kenneth-kovan

BioVaxys Technology Corp.: BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.

BioVaxys Technology Corp.: BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China , Canada , Frankfurt , Brandenburg , Germany , United-kingdom , United-states , Vancouver , British-columbia , Spain , British , Canadian

Annual Financial Statements Update for the Year Ended October 31, 2023

/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that as a result of delays in the...

United-states , Canada , United-kingdom , Vancouver , British-columbia , Spain , Frankfurt , Brandenburg , Germany , Canadian , British ,

BioVaxys Technology Corp.: Annual Financial Statements Update for the Year Ended October 31, 2023

BioVaxys Technology Corp.: Annual Financial Statements Update for the Year Ended October 31, 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China , Spain , United-kingdom , United-states , Frankfurt , Brandenburg , Germany , Canada , Vancouver , British-columbia , British , Canadian

BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.

/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce has completed the acquisition...

United-kingdom , Canada , Frankfurt , Brandenburg , Germany , United-states , Spain , Vancouver , British-columbia , British , Canadian , Kenneth-kovan

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

VANCOUVER, BC, Feb. 12, 2024 /PRNewswire/ -- BioVaxys Technology Corp. announced that it has executed the definitive Asset Purchase Agreement dated February 11th, 2024 to acquire the entire...

Frankfurt , Brandenburg , Germany , Spain , United-states , California , United-kingdom , Canada , Farmington , Connecticut , Vancouver , British-columbia

2024-02-12 | CSE:BIOV | Press Release | Biovaxys Technology Corp

(2024-02-12 | CSE:BIOV) BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

Canada , Vancouver , British-columbia , Germany , Farmington , Connecticut , United-states , United-kingdom , California , Frankfurt , Brandenburg , Spain

Biovaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, And Clinical Stage Assets Of The Former IMV Inc.

Biovaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, And Clinical Stage Assets Of The Former IMV Inc.
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Connecticut , United-states , Farmington , Canada , Frankfurt , Brandenburg , Germany , California , Spain , Vancouver , British-columbia

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada , Frankfurt , Brandenburg , Germany , United-kingdom , Farmington , Connecticut , United-states , Vancouver , British-columbia , California , Spain